Answer
Humira (adalimumab) is contraindicated in moderate to severe heart failure (NYHA class III/IV).
Sources for this answer
- Humira 40 mg solution for injection in pre-filled pen (Great Britain)AbbVie Ltd · emc · SmPC §4.3 Contraindications · Version 24Document updated
Sources checked